Advertisement

Topics

Latest "Global Initiative Alzheimer Disease Optum Labs" News Stories - Page: 4

22:12 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Global Initiative Alzheimer Disease Optum Labs" found in our extensive news archives from over 250 global news sources.

More Information about Global Initiative Alzheimer Disease Optum Labs on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global Initiative Alzheimer Disease Optum Labs for you to read. Along with our medical data and news we also list Global Initiative Alzheimer Disease Optum Labs Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global Initiative Alzheimer Disease Optum Labs Companies for you to search.

Showing "Global Initiative Alzheimer Disease Optum Labs" News Articles 76–100 of 31,000+

Relevant

If AI Is Going to Be the World’s Doctor, It Needs Better Textbooks

(Quartz) – Actually, you don’t have to imagine. This scenario is real. Winterlight Labs, a Toronto-based startup, is building auditory tests for neurological diseases like Alzheimer’s disease, Parkinson’s, and multiple sclerosis. But after publishing their initial research (pdf) in the … Read More


Whole Exome Sequencing Identifies New Alzheimer’s-Related Genes

Scientists at the Boston University School of Medicine with other researchers on the Alzheimer's Disease Sequencing Project (ADSP) have discovered new genes that could further current understanding of the genetic risk factors that predispose people to the development of Alzheimer's disease (AD). The ADSP was developed by the National Institutes of Health (NIH) in response to the National A...

Alzheimer’s burden to DOUBLE by 2060, CDC report warns – Daily Mail

Daily MailAlzheimer's burden to DOUBLE by 2060, CDC report warnsDaily MailThe number of Americans suffering from Alzheimer's is set to double by 2060, the Centers for Disease Control and Prevention (CDC) estimates. Alzheimer's disease is already crippling the minds of some 5.7 million Americans, and we have long expected a ...In 1960, about a half-million teens took an aptitude test. Now it could ...


EU countries unprepared to move future Alzheimer's treatment into rapid clinical use

(RAND Corporation) The burden of Alzheimer's disease in high-income countries is expected to nearly double by 2050 and recent positive results from clinical trials give hope that a disease-changing treatment could become available for routine use within a few years. But a new study finds that the health care systems in some European countries lack the capacity to rapidly move a disease-modifying t...

Study: Alzheimer's drug may stop disease if used before symptoms develop

(University of Virginia) Biologists have gained new understanding of how Alzheimer's disease begins, and how it might be halted using a current medication.

We Can Control One Of The Likely Causes Of Alzheimer's Disease

Over 5.5M people in the U.S. have Alzheimer's disease with an increase expected. We don't know the causes but research has shown it to be likely that heavy metal exposure is one of them. We can reduce our risk and that of our aging parents in several ways.

AstraZeneca, Eli Lilly terminate clinical trials of Alzheimer's disease treatment lanabecestat

AstraZeneca and Eli Lilly have announced the termination of global phase 3 clinical trials of Alzheimer's disease treatment, lanabecestat, which is an oral beta secretase cleaving enzyme (BACE) inhibitor.

Herpes virus linked to Alzheimer’s, antivirals may help – Independent Online

Independent OnlineHerpes virus linked to Alzheimer's, antivirals may helpIndependent OnlineLondon - Scientists have found evidence of a link between herpes infection and Alzheimer's disease as well as the potential of antivirals in reducing the risk of the neurodegenerative disease. In the study, when people who suffered with severe herpes ...Alzheimer's risk 10 times lower with herpes medicationM...

Evidence Mounts That an Eye Scan May Detect Early Alzheimer's Disease

CHICAGO, Oct. 28, 2018 /PRNewswire/ -- Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer's disease in a Read more...

Blood Test for Tau, Alzheimer's Disease Under Development

NewsInvestigators design, evaluate blood test for patients to detect tau, a hallmark of Alzheimer's disease.Contributed Author: 

Gut Microbiota Signature Altered in Alzheimer's Disease

The composition of gut microbiota is altered in patients with Alzheimer's disease, potentially supporting the inflammatory theory of the disease's pathogenesis, new research suggests. Medscape Medical News

Discovery and validation of autosomal dominant Alzheimer’s disease mutations

Alzheimer’s disease (AD) is a neurodegenerative disease that is clinically characterized by progressive cognitive decline. Mutations in amyloid-β precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (P...

Scientists Reveal a Gene Related to Alzheimer's Disease Using CRISPR

Cases of Alzheimer's disease (AD), the most common form of dementia, is mostly sporadic, making it difficult for scientists to determine how the disease starts and develops. Notably, researcher Carlos Pascual-Caro from University of Extremadura in Spain and colleagues pave a step forward into finding a cure for the disease by discovering a gene lin...

[Articles] Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Plasma NfL and CSF biomarkers have good diagnostic performance to detect Alzheimer's disease in adults with Down syndrome. Our findings support the utility of plasma NfL for the early detection of Alzheimer's disease in Down syndrome in clinical practice and clinical trials.

Senolytic Therapies Seem To Stop Alzheimer's Disease "In Its Tracks"

Scientists have implicated a type of cellular stress for the first time as a player in Alzheimer's disease. And their discovery could lead to treatments for more than 20 human brain diseases.

Senolytic Therapies Seem To Stop Alzheimer's Disease 'In Its Tracks'

Scientists have implicated a type of cellular stress for the first time as a player in Alzheimer's disease. And their discovery could lead to treatments for more than 20 human brain diseases.

European countries unprepared for Alzheimer's innovations, study shows

European healthcare systems are not prepared for new developments in preventative therapies for Alzheimer’s disease, according to research conducted by the American non-profit think tank, the RAND Corporation. While it is believed that Alzheimer’s disease is not curable, current hypotheses pose that the neurodegenerative condition may be prevented. There are currently therapies in development ...

PET imaging of tau may help distinguish Alzheimer Disease from other neurodegenerative disorders

1. In this cross-sectional study, the tau marker [18F]flortaucipir accurately distinguished Alzheimer’s Disease (AD) dementia from other non-AD neurodegenerative disorders about 90% of the time. 2. [18F]flortaucipir imaging more accurately identified AD compared to MRI-based measures of brain atrophy specific associated with AD. Evidence Rating Level: 2 (Good) Study Rundown: Alzheimer’s Diseas...

Report: Alzheimer’s market offers scope for disease-modifying drugs

The current competitive market for Alzheimer’s disease focuses only on symptomatic treatments, providing an opening for urgent new disease-modifying drugs...Read More... The post Report: Alzheimer’s market offers scope for disease-modifying drugs appeared first on Pharmaceutical Technology.

Salk Team Awarded 8-Year, $19.2M Grant for Alzheimer’s Research

A 10-person team of researchers at the Salk Institute for Biological Studies has been awarded an eight-year, $19.2 million grant to investigate mechanisms underlying Alzheimer’s disease and aging-related cognitive decline and uncover new therapies. The grant, announced Friday by the research institute in San Diego’s La Jolla community, is part of a $43 million initiative […]

Exosomes Shown to be Involved in Spread of Amyloid Beta in Alzheimer’s

Researchers report that exosomes appear to play a key role in the spread of Alzheimer's disease in the brain. Long understood that the main task of exosomes was to help the cell get rid of waste products, it’s now known that exosomes can contain both proteins and genetic material, which other cells can absorb, explain the scientists. In a new study (“ Alzheimer’s disease pathology pr...

Podcast: The problematic promise of a ‘cure’ for Alzheimer’s disease

The Alzheimer's Association has fundraising commercials promising breakthroughs and cures for a disease in which the cause is unknown and a treatment hasn't been found. Is this irresponsible? Unethical? Potentially harmful?

Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer's disease

Alzheimer's disease is a progressive, neurodegenerative condition in which individuals exhibit memory loss, dementia, and impaired metabolism.

Silicon valley philanthropist and Alzheimer's Association build the research pipeline

(Alzheimer's Association) Innovative research aimed to possibly rejuvenate brain cells is being funded by Alzheimer's Association grants as part of its ongoing efforts to fill the gap and accelerate the process in Alzheimer's disease drug development.

Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease

The post Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease appeared first on SynBioBeta.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks